These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8822529)

  • 41. Violence and serotonin: influence of impulse control, affect regulation, and social functioning.
    Krakowski M
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):294-305. PubMed ID: 12928505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects.
    Coccaro EF; Kavoussi RJ
    Arch Gen Psychiatry; 1997 Dec; 54(12):1081-8. PubMed ID: 9400343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life.
    Kiryanova V; Dyck RH
    Dev Neurosci; 2014; 36(5):396-408. PubMed ID: 25115143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.
    Berton O; Durand M; Aguerre S; Mormède P; Chaouloff F
    Neuroscience; 1999; 92(1):327-41. PubMed ID: 10392854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
    Constantino JN; Liberman M; Kincaid M
    J Child Adolesc Psychopharmacol; 1997; 7(1):31-44. PubMed ID: 9192540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postnatal fluoxetine treatment affects the development of serotonergic neurons in rats.
    Silva CM; Gonçalves L; Manhaes-de-Castro R; Nogueira MI
    Neurosci Lett; 2010 Oct; 483(3):179-83. PubMed ID: 20696211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behavioral and pharmacogenetics of aggressive behavior.
    Takahashi A; Quadros IM; de Almeida RM; Miczek KA
    Curr Top Behav Neurosci; 2012; 12():73-138. PubMed ID: 22297576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging the neural circuitry and chemical control of aggressive motivation.
    Ferris CF; Stolberg T; Kulkarni P; Murugavel M; Blanchard R; Blanchard DC; Febo M; Brevard M; Simon NG
    BMC Neurosci; 2008 Nov; 9():111. PubMed ID: 19014547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. USE OF ORAL FLUOXETINE FOR THE TREATMENT OF ABNORMAL AGGRESSION IN TWO RED-NECKED WALLABIES (MACROPUS RUFOGRISEUS).
    Olds JE
    J Zoo Wildl Med; 2017 Sep; 48(3):922-924. PubMed ID: 28920807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine.
    Pinna G; Dong E; Matsumoto K; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2035-40. PubMed ID: 12571361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute fluoxetine treatment increases aggressiveness in juvenile matrinxã (Brycon amazonicus).
    Wolkers CPB; Serra M; Barbosa Júnior A; Urbinati EC
    Fish Physiol Biochem; 2017 Jun; 43(3):755-759. PubMed ID: 28013422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin augmentation reduces response to attack in aggressive individuals.
    Berman ME; McCloskey MS; Fanning JR; Schumacher JA; Coccaro EF
    Psychol Sci; 2009 Jun; 20(6):714-20. PubMed ID: 19422623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of chronic fluoxetine on the behavior of dominant and subordinate naked mole-rats.
    Mongillo DL; Kosyachkova EA; Nguyen TM; Holmes MM
    Behav Brain Res; 2014 Jan; 258():119-26. PubMed ID: 24157335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring new compounds for functional imaging using a crayfish (Procambarus clarkia) aggression paradigm.
    Dingman S; Hurlburt L; Otte M
    Percept Mot Skills; 2009 Oct; 109(2):487-99. PubMed ID: 20038003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
    Cleare AJ; Bond AJ
    Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.